50th Amendment to the IFRA Code of Practice
On June 30, IFRA announced the notification of the 50th Amendment to the IFRA Standards. The Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. The amendment introduced one update to the Standards and one new prohibited substance – Mintlacton.
Marta Pinto

Marta Pinto

Regulatory Affairs Associate

FRAGRANCES, IFRA CODE OF PRACTICE AND THE NEW AMENDMENT

Fragrances are complex mixtures of aromatic substances of natural and/or synthetic origin that are added to cosmetics and personal care products to impart a pleasant and distinctive odour, mask the inherent odour of some ingredients and/or enhance the user experience of the product. However, some fragrance ingredients may have the potential to cause allergic contact skin reactions (like dermal sensitization).

It is possible to analyse these substances using a methodology called Quantitative Risk Assessment (QRA) to determine safe use levels of fragrance ingredients in a variety of consumer product types. Organizations such as the International Fragrance Association (IFRA) and the Research Institute for Fragrance Materials (RIFM) use QRA to conduct safety assessments. The International Fragrance Association (IFRA) was founded in 1973 and represents the interests of the fragrance industry worldwide. The IFRA Code of Practice is essentially the “global fragrance industry’s commitment to promoting the safe use of fragrance for everyone’s enjoyment”. Fragrance compliance means following the rules of the IFRA Code of Practice and the IFRA Standards (see previous post).

IFRA Code of Practice includes the manufacture and handling of all fragrance materials, for all types of applications. IFRA Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. These Standards limit or ban the usage of certain fragrance materials. IFRA gathers information regarding the safety of individual fragrance ingredients and reviews that information to determine their safety under expected conditions of product use. The conclusions of the IFRA safety reviews are published in the IFRA Code of Practice which provides critical guidance to fragrance formulators and cosmetic products manufacturers. New scientific developments about analysed substances often justify amendments to the Code and Standards.

On June 30 this year (2021), the notification of the 50th amendment to the IFRA Standards was issued. According to the notification, there is only one update to the Standards and one new prohibited substance (Mintlacton – CAS No. 13341-72-5). All other elements of the 49th Amendment addressing fragrance materials remain unchanged and in place. Timelines for implementation of the prohibition of use of Mintlacton were set as follows:

  • For new creations – 2 months after the date of the notification letter;
  • For existing creations – 13 months after the date of the notification letter.

The timelines set only apply to the supply of the fragrance mixtures, not to finished products.

Fragrance manufacturers and cosmetic companies have the responsibility to ensure that the fragrances used are safe and compliant with the IFRA Code of Practice and Standards. If you need further information or support on this subject, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. The International Fragrance Association (IFRA) – Notification of the 50th Amendment to the IFRA Standards. June 30, 2021.  
  3. The International Fragrance Association (IFRA) – Guidance for the use of IFRA Standards, 2019

further
reading

cosmetic products

May Butylphenyl Methylpropional be used in Cosmetic Products?

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation, the use of Butylphenyl Methylpropional will be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

How are Cosmetic Products Regulated in the United Arab Emirates?

The United Arab Emirates (UAE) are an emerging market for the beauty industry. Cosmetics and personal care products supplied or sold in the UAE must comply with the health and safety requirements set out in UAE legislation. Overall, the process for importing a cosmetic product into the UAE market from the European Union can be quite straightforward since the UAE has aligned several of its requirements with the European Cosmetic Regulation.

Read More »
cosmetic products

European Commission Report on Nanomaterials – 2021

The European Commission is required to submit to the European Parliament and the Council an annual status report on the use of nanomaterials in cosmetic products and to review the provisions concerning nanomaterials in the European Regulation (EC) No 1223/2009 on cosmetic products. In July 2021, the Commission has issued its latest annual report on this subject.

Read More »
cosmetic products

New Labelling Requirements for Cosmetic Products in China

The new Cosmetics Supervision and Administration Regulation (CSAR) was enacted in China. The National Medical Products Administration (NMPA) has released standards for the testing of cosmetic products’ safety profile and efficacy claims. The NMPA has also published the Administrative Measures on Cosmetics Labelling, an updated set of requirements for the label of cosmetic products made available in the Chinese market.

Read More »
cosmetic products

50th Amendment to the IFRA Code of Practice

On June 30, IFRA announced the notification of the 50th Amendment to the IFRA Standards. The Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. The amendment introduced one update to the Standards and one new prohibited substance – Mintlacton.

Read More »
medical devices

EN ISO 13485:2016 – Amendment 11 has been published!

The European standardisation bodies CEN and CENELEC published EN ISO 13485:2016+A11:2021 featuring new annexes ZA and ZB that link the requirements of the MDR (Regulation EU 2017/745) and the IVDR (Regulation EU 2017/746), respectively, to specific clauses of the standard.

Read More »
cosmetic products

How are Cosmetic Products Regulated in India?

The different expectations and needs of consumers are continually changing and therefore the cosmetic industry needs to be gradually evolve to meet the new consumer’s demand. In this regard, India has recently introduced some regulatory updates to ensure that cosmetics placed on the market are safer for all consumers.

Read More »
cosmetic products

Is Phenoxyethanol Safe for Use in All Cosmetic Products?

Phenoxyethanol is a common preservative used in cosmetic and personal care products worldwide. It has been subject to various safety assessments and most concluded about its safety under the current most frequent uses. Nevertheless, some concerns were raised by the French Agency ANSM, particularly regarding its use in products intended for the nappy area in children up to 3 years old.

Read More »
cosmetic products

Cannabis-Derived Ingredients in Cosmetic Products

Cannabis-derived ingredients are popular compounds with interesting properties. There is specific EU and national legislation regarding cannabis-derived ingredients, identifying which extracts and derivatives may be used in cosmetic products. There are several aspects to consider to ensure compliance when adding these compounds to cosmetics and personal care products.

Read More »
cosmetic products

Cosmetic Products Testing in the European Union

A cosmetic product which is made available on the European Union market needs to prove that it is safe for consumers. Apart from the mandatory testing, depending on the claims to be used or the type of cosmetic product to be placed on the market, additional tests may be required.

Read More »
COVID-19

New EU Commission Recommendation for PPE and Medical Devices – COVID-19

PPE and Medical Devices have proven to be essential for healthcare workers in the efforts to contain the COVID-19 outbreak. In March 2020, the EU Commission urged the economic operators to increase rapid supply into the market. Currently, the Commission considers that the conditions for exceptional access to market are no longer met, limiting the placing of PPE and Medical Devices which have not successfully undergone the relevant conformity assessment procedures applicable on the EU market.

Read More »